Development of cancer treatments based on NMT inhibition for antibody-drug conjugates.
C
CSR Analysis score
The organization is among the 50% most committed organizations, excluding the top 20%, among comparable organizations.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including Myricx Pharma's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: September 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Oncodesign
B
Development of innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution, with a focus on precision medicine.
Lys Therapeutics
B
Development of first-in-class monoclonal antibodies to treat neurodegenerative and neurovascular diseases by targeting neuroinflammation and blood-brain barrier dysfunction.
Alentis Therapeutics
B
Development of innovative treatments targeting Claudin-1 for cancer and organ fibrosis. The company develops antibodies and antibody-drug conjugates to treat Claudin-1-positive tumors and multi-organ fibrotic diseases.
Initiatives identified among leaders
Mesure et réduction collaborative de l'empreinte carbone depuis 2022
“Depuis septembre 2022, Oncodesign mesure son empre...” - OncodesignPrésentation de données précliniques sur une maladie neurodégénérative
“Lys Therapeutics présente des données précliniques...” - Lys Therapeutics28% of similar organizations communicate on CSR issues
+77 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports